Home › Funds › BEACON HILL WEALTH MANAGEMENT LTD. › AKBA
BEACON HILL WEALTH MANAGEMENT LTD. position in AKBA
AKEBIA THREAPEUTICS INC · Health Care
BEACON HILL WEALTH MANAGEMENT LTD. reported holding 20,000 shares of AKBA (AKEBIA THREAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$23K, representing 0.02% of its reported portfolio and ranking #27 among its reported holdings. BEACON HILL WEALTH MANAGEMENT LTD. first reported this position in Q2 2026.
How BEACON HILL WEALTH MANAGEMENT LTD.'s AKBA position evolved
BEACON HILL WEALTH MANAGEMENT LTD. first disclosed a stake in AKBA in Q2 2026 at 20,000 shares (US$23K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 20.00K | $22.80K | New |
About AKBA and 13F data
AKBA (AKEBIA THREAPEUTICS INC) is a Health Care company. 25 other funds we track also report a position in AKBA. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.